Project Grant R01MD021665
- The National Institute for Minority Health and Health Disparities awarded Kaiser Foundation Hospitals (Kaiser Permanente) $10.492 million on September 19, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307). The award funds a mixed-methods implementation science study examining racial and ethnic disparities in depression treatment and outcomes across five health systems in seven states (California, Texas, Georgia, Minnesota, Michigan, North Dakota, and...
- The National Institute for Minority Health and Health Disparities awarded the University of Houston System $445,168 on July 5, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and validate a depression screening instrument tailored for patients with sickle cell disease. The project addresses a critical diagnostic gap: current screening tools such as the Patient Health Questionnaire-9 fail to distinguish depressive symptoms from somatic symptoms...
- The National Institute of Mental Health awarded Drexel University $333,868 on June 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to design, develop, and pilot test a web-based digital mental health intervention for Black male emerging adults with depression. The project uses community-based participatory research as a guiding framework across all phases, from study design to dissemination. Work includes focus groups with Black men and key stakeholders to identify...
- The National Institute for Minority Health and Health Disparities awarded the University of Rochester $2,057,213 on September 14, 2025 under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct an observational study examining how daily social engagement influences suicide risk in adults aged 40 and older with elevated suicide risk. The study enrolls 200 adults with past-year suicide ideation or lifetime suicide attempt history. Participants complete baseline...
- The National Institute of Mental Health awarded Trustees of Indiana University $2.938 million on September 24, 2025, under the Mental Health Research Grants program (CFDA 93.242) to investigate maternal depression trajectories across 25 years in relation to sociocultural risk factors and a randomized parenting intervention. The recipient will examine variation in depression trajectories among low-income mothers across two decades, prospectively analyzing how sociodevelopmental characteristics,...
- The National Institute for Minority Health and Health Disparities awarded The University of Chicago $830,875 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and evaluate a primary care model addressing interconception care—healthcare services provided after pregnancy to support optimal outcomes in future pregnancies. The award supports research on how primary care providers can address treatable chronic diseases including diabetes,...
- The National Institute on Minority Health and Health Disparities, part of the Department of Health and Human Services National Institutes of Health, awarded the University of Illinois $5,959,150 on September 14, 2025, for a randomized controlled trial examining the effectiveness of a food-is-medicine intervention to promote healthy eating and blood pressure control in hypertensive Black women with obesity. The FIM+DASH trial will deliver cooking classes, nutrition and hypertension education, and...
- The National Institute of Mental Health, under the Department of Health and Human Services, awarded the University of California, San Diego $199,271 on September 1, 2026, for a randomized, double-blind, sham-controlled trial of home-based spaced transcranial direct current stimulation (tDCS) in adults with treatment-resistant depression. The award funds investigation of a novel spaced tDCS protocol—involving multiple daily sessions separated by short intervals—designed to better engage...
- The National Institute of Mental Health awarded the University of Connecticut Health Center $840,674 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a comprehensive study examining the independent effect of depression on financial capacity in older adults. The research tests a conceptual framework—the Mood, Motivation and Social Cognition Model of Diminished Financial Capacity in Late-Life Depression—to identify how specific behavioral features of...
- The National Institute of Mental Health awarded Indiana University $853,969 on September 24, 2025, under the Mental Health Research Grants program (CFDA 93.242) to investigate maternal depression trajectories across 25 years in low-income families participating in a randomized parenting intervention trial. The project analyzes longitudinal data from 731 low-income families enrolled in the Early Steps Multisite (ESM) study, assessed 13 times from child ages 2 to 19. Investigators will identify...
The National Institute for Minority Health and Health Disparities awarded Temple University $792,498 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a cluster randomized controlled trial evaluating shared decision-making interventions for depression care in safety-net primary care settings. The ENGAGE-D trial is a two-arm study that tests the effectiveness of a shared decision-making intervention designed to improve communication between primary care providers and patients with depression. The intervention includes provider training, a patient encounter decision aid, and structured discussion protocols to enable primary care providers to facilitate collaborative treatment decisions during routine visits. The trial will enroll 300 patients with depression clustered across 16 primary care providers (8 per arm) in safety-net settings, comparing the intervention against treatment as usual. The award addresses a documented gap in depression care delivery: primary care providers, who deliver the majority of depression treatment particularly in safety-net environments, often lack sufficient time and structured tools to discuss treatment options, assess patient preferences, or present alternatives to patients. The research hypothesis holds that shared decision-making improves treatment engagement and health outcomes by aligning clinical recommendations with patient values and preferences while enhancing patient understanding of diagnosis and available options. Performance occurs in Philadelphia, Pennsylvania, with work extending from September 1, 2026, through March 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $792.5k | 9/1/26 |